Pilot to evaluate the feasibility of measuring seasonal influenza vaccine effectiveness using surveillance platforms in Central-America, 2012

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  El Omeiri, Nathalie ^a,h   Azziz Baumgartner, Eduardo ^b   Clará, Wilfrido ^b   Guzmán Saborío, Guiselle ^c   Elas, Miguel ^d   Mejía, Homer ^e   Molina, Ida Berenice ^e   De Molto, Yadira ^f   Mirza, Sara ^b   Widdowson, Marc Alain ^b   Ropero Álvarez, Alba María ^g  

^a Taskforce for Global Health Inc   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^d Ministry of Health   (El Salvador)

^e Ministry of Health   (Honduras)

^f Ministry of Health   (Panama)

^g PAN AMERICAN HEALTH ORGANIZATION   (United States)

^h Pan American Health Organization   (Panama)

Author keywords

Adults; Children; Effectiveness; Hospitalization; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

AGED; CASE CONTROL STUDY; CENTRAL AMERICA; CHILD; FEMALE; HOSPITAL LABORATORY; HUMAN; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PILOT STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SAMPLE SIZE; SEASON; SENTINEL SURVEILLANCE;

AGED; CASE-CONTROL STUDIES; CENTRAL AMERICA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; LABORATORIES, HOSPITAL; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; SAMPLE SIZE; SEASONS; SENTINEL SURVEILLANCE;

EID: 85018138355     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2001-1     Document Type: Article

References (33)

1. Savy V, Ciapponi A, Bardach A, Glujovsky D, Aruj P, Mazzoni A, et al. Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis. Influenza Other Respi Viruses. 2013;7(6):1017-32. PubMed.
2. Azziz-Baumgartner E, Cabrera AM, Chang L, Calli R, Kusznierz G, Baez C, et al. Mortality, severe acute respiratory infection, and influenza-like illness associated with influenza A(H1N1)pdm09 in Argentina, 2009. PLoS One. 2012;7(10):e47540. PubMed Pubmed Central PMCID: 3485247.
3. Freitas AR, Francisco PM, Donalisio MR. Mortality associated with influenza in tropics, state of sao paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic, and post-pandemic periods. Influenza Res Treatment. 2013;2013:696274. PubMed Pubmed Central PMCID: 3694379.
4. Clara W, Armero J, Rodriguez D, de Lozano C, Bonilla L, Minaya P, et al. Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010. Bull World Health Organ. 2012;90(10):756-63. PubMed Pubmed Central PMCID: 3471049.
5. WHO. Prevention and control of influenza pandemics and annual epidemics. Fifty-sixth World Health Assembly, Resolution WHA56.19.28. Geneva. 2003. Available from: http://apps.who.int/gb/archive/pdf-files/WHA56/ea56r19.pdf.
6. Ropero-Alvarez AM, Kurtis HJ, Danovaro-Holliday MC, Ruiz-Matus C, Andrus JK. Expansion of seasonal influenza vaccination in the Americas. BMC Public Health. 2009;9:361.
7. Vaccines against influenza WHO position paper -Weekly Epidemiological Record. No. 47, 2012, 87, 461-476. 23 November 2012. Available at: http://www.who.int/wer/2012/wer8747.pdf
8. Centers for Disease Control Prevention. Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep. 2013;62(7):119-23. PubMed.
9. Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis. 2013;57(6):820-7. PubMed Pubmed Central PMCID: 3749748.
10. Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter AL, Mahmud SM, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro surveill. 2013;18(5). PubMed
11. Gutierrez EB, Li HY, Santos AC, Lopes MH. Effectiveness of influenza vaccination in elderly outpatients in Sao Paulo city, Brazil. Rev Inst Med Trop Sao Paulo. 2001;43(6):317-20. PubMed.
12. Mesa Duque SS, Perez Moreno A, Hurtado G, Arbelaez Montoya MP. [Effectiveness of an influenza vaccine in a working population in Colombia]. Pan Am J Public Health. 2001;10(4):232-9. PubMed Efectividad de una vacuna antigripal en una poblacion laboral colombiana.
13. Orellano PW, Reynoso JI, Carlino O, Uez O. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine. 2010;28(32):5288-91. PubMed.
14. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623-31. PubMed.
15. Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. PLoS One. 2013;8, e59681.
16. McNeil SA, Shinde V, Andrew M, Hatchette TF, Leblanc J, Ambrose A, et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro Surveill. 2014;19(9)
17. Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine. 2014;32(29):3687-93. ISSN 0264-410X, http://dx.doi.org/10.1016/j.vaccine.2014.04.013.
18. PAHO. Operational guidelines for intensified national surveillance of SARI. 2011. Available from: http://www.paho.org/hq./index.php?option=com-docman&task=doc-view&gid=17126&Itemid.
19. CDC-PAHO. Generic Protocol for Influenza Surveillance. 2006.
20. Berman L. CDC Real-time RT-PCR Protocol for Detection and Characterization of Influenza 2012; Virus Surveillance and Diagnosis Branch, June 8, Influenza Division.
21. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010;28(46):7381-8. PubMed.
22. García J, Sovero M, Torres AL, Gomez J, Douce R, Barrantes M, et al. Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza Other Respi Viruses. 2009;3(2):69-74.
23. Valenciano M, Ciancio B, team IMs. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39). PubMed
24. Eisenberg KW, Szilagyi PG, Fairbrother G, Griffin MR, Staat M, Shone LP, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics. 2008;122(5):911-9. PubMed Pubmed Central PMCID: 3695734.
25. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis. 2012;55(3):332-42. PubMed.
26. Cheng AC, Holmes M, Irving LB, Brown SG, Waterer GW, Korman TM, et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS One. 2013;8(7):e68760. PubMed Pubmed Central PMCID: 3712933.
27. Gross PA, Russo C, Dran S, Cataruozolo P, Munk G, Lancey SC. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol. 1997;4(4):491-2. PubMed Pubmed Central PMCID: 170557.
28. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;87(47):461-76. PubMed
29. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 2: The Design and Analysis of Cohort Studies, IARC Scientific Publications No. 82. Lyon, France: International Agency of Research on Cancer; 1987. p. 305 6.Sections 7.8-7.9
30. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley; 1981.
31. Azziz Baumgartner E, Dao C, Nasreen S, Bhuiyan MU, Mah-E-Muneer S, Mamun AA, et al. Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis. 2012;206(6):838-46. doi: 10.1093/infdis/jis467.
32. World Health Organization. Immunization coverage, the administrative method. Available at: http://www.who.int/immunization/monitoring-surveillance/routine/coverage/en/index1.html
33. World Health Organization. International Health Regulations, Annex 2. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Available at: http://apps.who.int/medicinedocs/documents/s19133en/s19133en.pdf